Changing Life Sciences Value Chain

Archives for December 2009 « Recent Articles

Photo of Eric NewmarkOffline

CRM/SFA: Guidelines for System Selection

By Eric Newmark

Life science companies face significant challenges around the sales and marketing environment, as OIG regulations, the Physician Payments Sunshine Act, the new PhRMA code, and state-by-state mandates quickly reshape operating guidelines. In response, some companies are evaluating enhanced CRM,/SFA solutions to increase their sales and marketing capabilities and promotional competitiveness.

Photo of Dr. Alan S. LouieOffline

The life science industry continues to move forward as it tries desperately to fill expected loss of revenue from drug blockbusters over the next several years.  Major M&A between mega pharmaceutical companies promises to restore profitability through increased operational efficiency, although this approach can only hope to maintain a somewhat proportionate rate of return at a lower combined revenue level.  Acquisitions of smaller biotechnology companies are a higher risk bet on the success of

Viewed 759,745 times